Related Experiment Videos
Summary
For acne patients unresponsive to tetracycline, low-dose clindamycin offers significant improvement. This study found a majority of difficult acne cases cleared or improved substantially with clindamycin treatment.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Tetracycline is a primary treatment for chronic acne maintenance due to its efficacy, safety, and cost-effectiveness.
- A subset of patients with severe or recalcitrant acne does not achieve satisfactory results with tetracycline therapy.
Purpose of the Study:
- To evaluate the effectiveness of low-dose clindamycin in patients with nodulocystic acne who were treatment-resistant to tetracycline.
Main Methods:
- Forty-two patients diagnosed with nodulocystic acne and inadequate response to tetracycline were enrolled.
- Participants were switched to a low-dose clindamycin regimen for treatment.
Main Results:
- A majority of patients experienced significant improvement in their nodulocystic acne.
- Nine patients achieved essential clearing of the condition.
- Two patients reported transient diarrhea, which resolved upon discontinuation of clindamycin.
Conclusions:
- Low-dose clindamycin is a viable and effective alternative treatment for patients with nodulocystic acne refractory to tetracycline.
- Clindamycin demonstrates a favorable safety profile for acne management, with minimal adverse effects.